Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure

ML Copersino, DJ Schretlen… - The American journal …, 2012 - Taylor & Francis
Background and objectives: Neuropsychological impairment among patients with substance
use disorders (SUDs) contributes to poorer treatment processes and outcomes. However …

Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure

ML Copersino, DJ Schretlen… - … journal of drug …, 2012 - pubmed.ncbi.nlm.nih.gov
Background and objectives Neuropsychological impairment among patients with substance
use disorders (SUDs) contributes to poorer treatment processes and outcomes. However …

[PDF][PDF] Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure

E Lukas, L Judith Faberman, J Sokoloff… - Am J Drug Alcohol …, 2012 - researchgate.net
Abstract Background and Objectives—Neuropsychological impairment among patients with
substance use disorders (SUDs) contributes to poorer treatment processes and outcomes …

Effects of cognitive impairment on substance abuse treatment attendance: Predictive validation of a brief cognitive screening measure

ML Copersino, DJ Schretlen… - American Journal of …, 2012 - pure.johnshopkins.edu
Background and objectives: Neuropsychological impairment among patients with substance
use disorders (SUDs) contributes to poorer treatment processes and outcomes. However …

Effects of cognitive impairment on substance abuse treatment attendance: Predictive validation of a brief cognitive screening measure.

ML Copersino, DJ Schretlen… - The American Journal …, 2012 - psycnet.apa.org
Background and objectives: Neuropsychological impairment among patients with substance
use disorders (SUDs) contributes to poorer treatment processes and outcomes. However …

Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.

ML Copersino, DJ Schretlen, GM Fitzmaurice… - 2012 - cabidigitallibrary.org
Background and objectives: Neuropsychological impairment among patients with substance
use disorders (SUDs) contributes to poorer treatment processes and outcomes. However …

[PDF][PDF] Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure

E Lukas, L Judith Faberman, J Sokoloff… - Am J Drug Alcohol …, 2012 - academia.edu
Abstract Background and Objectives—Neuropsychological impairment among patients with
substance use disorders (SUDs) contributes to poorer treatment processes and outcomes …

[HTML][HTML] Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure

ML Copersino, DJ Schretlen, G Fitzmaurice… - The American journal …, 2012 - ncbi.nlm.nih.gov
Methods We compared previously-collected clinical assessment data on 60 SUD patients
receiving treatment in a program of short duration and high intensity to attendance data …

Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.

ML Copersino, DJ Schretlen… - The American Journal …, 2012 - europepmc.org
Methods We compared previously collected clinical assessment data on 60 SUD patients
receiving treatment in a program of short duration and high intensity to attendance data …